Publication | Open Access

Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death

Transplant RejectionTransplantationPreemptive TreatmentMedicineLung Transplant PatientsDonor-specific AntibodiesImmunologyAutoimmunityGraft SurvivalGraft RejectionImmunotherapyLung TransplantationTransplant Immunology